ASPR to invest in domestic production of ingredient for pain management, overdose reversal medications

The Administration for Strategic Preparedness and Response announced March 5 that it will invest in the domestic production of thebaine, an ingredient used to manufacture medications for pain management, alcohol use disorder and the reversal of opioid overdose. ASPR said Antheia, Inc., based in Menlo Park, Calif., will receive funding to produce the ingredient. The investment is the latest effort by ASPR and the Department of Health and Human Services to reduce reliance on foreign resources and increase the domestic production of essential medications and their active pharmaceutical ingredients.